Cargando…

A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes

Prophylaxis with neuraminidase inhibitors is important for controlling seasonal influenza outbreaks in long-term care settings. We used a stochastic individual-based model that simulates influenza virus transmission in a long-term care nursing home department to study the protection offered to patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Dool, Carline, Hak, Eelko, Bonten, Marc J.M., Wallinga, Jacco
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866379/ https://www.ncbi.nlm.nih.gov/pubmed/19861044 http://dx.doi.org/10.3201/eid1510.081129

Ejemplares similares

The Effects of Influenza Vaccination of Health Care Workers in Nursing Homes: Insights from a Mathematical Model
por: van den Dool, Carline, et al.
Publicado: (2008)

The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network
por: van den Dool, Carline, et al.
Publicado: (2016)

Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons
por: van der Sande, Marianne AB, et al.
Publicado: (2014)

Modeling the impacts of influenza antiviral prophylaxis strategies in nursing homes
por: Zipfel, Casey, et al.
Publicado: (2023)

Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
por: Dronavalli, Mithilesh, et al.
Publicado: (2020)

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
por: Davies, Brian E.
Publicado: (2010)

Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children
por: Reisinger, Keith, et al.
Publicado: (2012)

Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses
por: Bird, Nicola L., et al.
Publicado: (2015)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
por: Lee, Vernon J, et al.
Publicado: (2010)

Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
por: Hsieh, Nan-Hung, et al.
Publicado: (2017)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season
por: Coleman, Brenda L., et al.
Publicado: (2011)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
por: Oh, Ding Yuan, et al.
Publicado: (2014)

Staff exchange within and between nursing homes in The Netherlands and potential implications for MRSA transmission
por: VAN GAALEN, R. D., et al.
Publicado: (2017)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
por: Boianelli, Alessandro, et al.
Publicado: (2016)

Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003
por: te Beest, Dennis E., et al.
Publicado: (2010)

Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-analysis
por: Hanula, Ryan, et al.
Publicado: (2023)

Variation in loss of immunity shapes influenza epidemics and the impact of vaccination
por: Woolthuis, Rutger G., et al.
Publicado: (2017)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Maternal and Perinatal Outcomes of Influenza in Pregnancy after Treatment with Oseltamivir
por: Abraham, Kavitha, et al.
Publicado: (2021)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
por: Honce, Rebekah, et al.
Publicado: (2023)

How to develop a program to increase influenza vaccine uptake among workers in health care settings?
por: Looijmans-van den Akker, Ingrid, et al.
Publicado: (2011)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis
por: Ye, Ming, et al.
Publicado: (2016)

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
por: Goldstein, Edward, et al.
Publicado: (2010)

Transmission of Novel Influenza A(H1N1) in Households with Post-Exposure Antiviral Prophylaxis
por: van Boven, Michiel, et al.
Publicado: (2010)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
por: Anekthananon, T., et al.
Publicado: (2013)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
por: Anekthananon, T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rg52lg3be9ulj75qjqk1st42ud